カテゴリー: 2024年度

Isaac Ngare ,Toong Seng Tan 1,Mako Toyoda 1,Takeo Kuwata 1,Soichiro Takahama ,Eriko Nakashima 3,Naoya Yamasaki ,Chihiro Motozono 1,Teruhisa Fujii ,Rumi Minami ,Godfrey Barabona ,Takamasa Ueno

Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV

Viruses

For more detail➡

Begum MM, Ichihara K, Takahashi O, Nasser H, Jonathan M, Tokunaga K, Yoshida I, Nagashima M, Sadamasu K, Yoshimura K, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Sato K, Ikeda T* (*correspondence)

Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity.

Front Virol.

Click for more details→

Islam MS, Rabin NN, Begum MM, Goto N, Tagawa R, Nagashima M, Sadamasu K, Yoshimura K, Sekine Y, Ikeda T*, Hayami S* (*equal correspondence).

Assessing the efficacy of GO-anchored filters versus various commercial masks.

RSC Appl Interfaces

Click for more details→

Tamura T#, Mizuma K#, Nasser H#, Deguchi S#, Padilla-Blanco M#, Uriu K#, Tolentino JEM# (#equal contribution), Tsujino S, Suzuki R, Kojima I, Nao N, Shimizu R, Jonathan M, Kosugi Y, Guo Z, Hinay Jr. AA, Putri O, Kim Y, Tanaka YL, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Saito A, Ito J, Irie T, Zahradnik J*, Ikeda T*, Takayama K*, Matsuno K*, Fukuhara T*, Sato K* (*equal correspondence).

Virological characteristics of the SARS-CoV-2 BA.2.86 variant.

Cell Host Microbe.

Click for more details　→